AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

(2013) Miki Okada-Iwabu et al.   NATURE

Ronning After the Adiponectin Receptors

(2013) W. L. Holland et al.   SCIENCE

Impact of a Single Intracoronary Administration of Adiponectin on Myocardial Ischemia/Reperfusion Injury in a Pig Model

(2010) Kazuhisa Kondo et al.   Circulation-Cardiovascular Interventions

Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action

(2009) Yajing Wang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Antagonism of Human Adiponectin Receptors and Their Membrane Progesterone Receptor Paralogs by TNFα and a Ceramidase Inhibitor

(2009) Brian R. Kupchak et al.   BIOCHEMISTRY

AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin

(2009) Yajing Wang et al.   CIRCULATION

Adiponectin Deficiency, Diastolic Dysfunction, and Diastolic Heart Failure

(2009) Flora Sam et al.   ENDOCRINOLOGY

Adiponectin identified as an agonist for PAQR3/RKTG using a yeast-based assay system

(2009) Ibon Garitaonandia et al.   JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Usefulness of Adiponectin to Predict Myocardial Salvage Following Successful Reperfusion in Patients With Acute Myocardial Infarction

(2008) Rei Shibata et al.   AMERICAN JOURNAL OF CARDIOLOGY

Protective vascular and myocardial effects of adiponectin

(2008) Barry J Goldstein et al.   Nature clinical practice. Cardiovascular medicine